CorMedix Inc buy stratec
Start price
18.03.20
/
50%
€2.02
Target price
04.11.21
€8.00
Performance (%)
115.84%
End price
05.11.21
€4.36
Summary
This prediction ended on 05.11.21 with a price of €4.36. With a performance of 115.84% the BUY prediction by stratec was a big success. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CorMedix Inc | -6.167% | -6.167% | 23.121% | -19.623% |
| iShares Core DAX® | -0.116% | 1.953% | 14.155% | 16.268% |
| iShares Nasdaq 100 | -2.733% | -1.273% | 31.828% | 43.377% |
| iShares Nikkei 225® | -1.721% | 3.263% | 12.922% | 8.501% |
| iShares S&P 500 | -1.527% | 0.194% | 27.117% | 41.752% |
Comments by stratec for this prediction
In the thread CorMedix Inc diskutieren
CorMedix has seen some positive analyst action this week. Yesterday, B Riley FBR reissued its Buy rating and $10 price target on this New Jersey based 'Tier 4' concern that is focus on commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. Today, H.C. Wainwright maintains its Buy rating and $14 price target on CRMD.
In the thread Trading CorMedix Inc
Die von stratec gewählte maximale Laufzeit wurde überschritten